Medivolve Inc
OTC:MEDVF

Watchlist Manager
Medivolve Inc Logo
Medivolve Inc
OTC:MEDVF
Watchlist
Price: 0.007 USD 16.67% Market Closed
Market Cap: 22.8m USD
Have any thoughts about
Medivolve Inc?
Write Note

Medivolve Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medivolve Inc
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Medivolve Inc
OTC:MEDVF
Current Portion of Long-Term Debt
CA$43.3k
CAGR 3-Years
-81%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Andlauer Healthcare Group Inc
TSX:AND
Current Portion of Long-Term Debt
CA$26.5m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
N/A
WELL Health Technologies Corp
TSX:WELL
Current Portion of Long-Term Debt
CA$61m
CAGR 3-Years
162%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
dentalcorp Holdings Ltd
TSX:DNTL
Current Portion of Long-Term Debt
CA$28m
CAGR 3-Years
-3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
KDA Group Inc
XTSX:KDA
Current Portion of Long-Term Debt
CA$58.2k
CAGR 3-Years
-74%
CAGR 5-Years
-63%
CAGR 10-Years
N/A
H
Healwell Al Inc
TSX:AIDX
Current Portion of Long-Term Debt
CA$1m
CAGR 3-Years
-26%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
No Stocks Found

Medivolve Inc
Glance View

Market Cap
22.8m USD
Industry
Health Care

Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. The company offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. The company is also engaged in developing technologies to identify, treat, and prevent medical issues. The company provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The firm uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.

MEDVF Intrinsic Value
0.004 USD
Overvaluation 49%
Intrinsic Value
Price

See Also

What is Medivolve Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
43.3k CAD

Based on the financial report for Dec 31, 2023, Medivolve Inc's Current Portion of Long-Term Debt amounts to 43.3k CAD.

What is Medivolve Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
-81%

Over the last year, the Current Portion of Long-Term Debt growth was -90%. The average annual Current Portion of Long-Term Debt growth rates for Medivolve Inc have been -81% over the past three years .

Back to Top